# Bioequivalence Study of Dr. Reddy's Laboratories Limited Fexofenadine Hydrochloride 180 mg Tablets Under Fed Conditions

> **NCT01066767** · PHASE1 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 30 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Fexofenadine

## Key facts

- **NCT ID:** NCT01066767
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-04
- **Primary completion:** 2002-05
- **Final completion:** 2002-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2010-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01066767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01066767, "Bioequivalence Study of Dr. Reddy's Laboratories Limited Fexofenadine Hydrochloride 180 mg Tablets Under Fed Conditions". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01066767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*